These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2575146)

  • 41. The role of dopamine in the maintenance and breakdown of D1/D2 synergism.
    LaHoste GJ; Marshall JF
    Brain Res; 1993 May; 611(1):108-16. PubMed ID: 8518938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Motor effects of lamotrigine in naive and dopamine-depleted mice.
    Kaur S; Starr M
    Eur J Pharmacol; 1996 May; 304(1-3):1-6. PubMed ID: 8813577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid development of dopaminergic supersensitivity in reserpine-treated rats demonstrated with 14C-2-deoxyglucose autoradiography.
    Trugman JM; James CL
    J Neurosci; 1992 Jul; 12(7):2875-9. PubMed ID: 1613560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
    Shen RY; Asdourian D; Chiodo LA
    Synapse; 1992 Aug; 11(4):319-29. PubMed ID: 1354398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The thermogenic actions of alpha 2-adrenoceptor agonists in reserpinized mice are mediated via a central postsynaptic alpha 2-adrenoceptor mechanism.
    Bill DJ; Hughes IE; Stephens RJ
    Br J Pharmacol; 1989 Jan; 96(1):133-43. PubMed ID: 2564288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yawning and suppression of exploration induced by dopamine agonists: no relation to extracellular striatal levels of dopamine.
    Ståhle L; Ungerstedt U
    Pharmacol Biochem Behav; 1990 Jan; 35(1):201-9. PubMed ID: 1969163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The rise of body temperature induced by the stimulation of dopamine D1 receptors is increased in acutely reserpinized mice.
    Vasse M; Chagraoui A; Henry JP; Protais P
    Eur J Pharmacol; 1990 May; 181(1-2):23-33. PubMed ID: 1974857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic electroconvulsive shock alters hypothermic response of B-HT 920 and SKF 38393 in rats.
    Verma A; Kulkarni SK
    J Pharm Pharmacol; 1991 Nov; 43(11):813-4. PubMed ID: 1686915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE; Holtzman SG
    Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I; Bryer JB; Starkstein SE; Honig M; Moran TH; Robinson RG
    Brain Res; 1990 Nov; 533(2):286-91. PubMed ID: 1981170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
    Sharma A; Kulkarni SK
    Indian J Exp Biol; 1994 Mar; 32(3):176-9. PubMed ID: 8070837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haloperidol-induced vacuous chewing in rats: suppression by alpha-methyl-tyrosine.
    Diana M; Collu M; Mura A; Gessa GL
    Eur J Pharmacol; 1992 Feb; 211(3):415-9. PubMed ID: 1352256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic behavioural effects of dopamine D1 and D2 receptor agonists are determined by circadian rhythms.
    Martin-Iverson MT; Yamada N
    Eur J Pharmacol; 1992 Apr; 215(1):119-25. PubMed ID: 1355440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The behavioral effects of the stereoisomers of 4-methylaminorex, a psychostimulant, in the rat.
    Batsche K; Ashby CR; Lee C; Schwartz J; Wang RY
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1029-39. PubMed ID: 7912274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.